Home › Melanoma › North Carolina › Durham
Studi clinici su Melanoma a Durham, NC
21 studi su Melanoma cercano partecipanti presso sedi a Durham e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Durham VA Medical Center, Durham
NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
In reclutamentoFase 2
- Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi di distanza
DESTINY-PANTUMOUR04
In reclutamentoStudio osservazionale
- Research Site, Durham
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
In reclutamentoFase 3
- Duke Health System, Durham
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
In reclutamentoFase 3
- Duke University Medical Center, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
In reclutamentoFase 2
- Local Institution - 0100, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
In reclutamentoStudio osservazionale
- UNC- Chapel Hill, Chapel Hill · a 10 mi di distanza
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
In reclutamentoFase 1/2
- University of North Carolina, Chapel Hill · a 10 mi di distanza
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
In reclutamentoFase 1/2
- Duke Cancer Institute, Durham
Project: Every Child for Younger Patients With Cancer
In reclutamentoStudio osservazionale
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi di distanza
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
In reclutamentoFase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi di distanza
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
In reclutamentoFase 1
- Duke University Medical Center, Durham
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
In reclutamentoFase 1/2
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · a 10 mi di distanza
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
In reclutamentoFase 1/2
- Duke University Medical Center, Durham
IL-17 Blockade to Decrease irAEs (REPLAY)
In reclutamentoFase 1
- Duke University Health System, Durham
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
In reclutamentoFase 1/2
- University of North Carolina at Chapel Hill, Chapel Hill · a 10 mi di distanza
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
In reclutamentoFase 2/3
- Duke University Medical Center, Durham
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
In reclutamentoFase 3
- Duke University Medical Center - Duke Cancer Center, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Chapel Hill · a 10 mi di distanza
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
In reclutamento
- Duke University Health System, Durham
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
In reclutamento
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · a 10 mi di distanza
- University of North Carolina Hospitals - Hillsborough Campus, Hillsborough · a 13 mi di distanza
Studi su Melanoma in altre città
- Houston, TX59 studi
- New York City, NY38 studi
- Los Angeles, CA34 studi
- Nashville, TN33 studi
- Pittsburgh, PA31 studi
- Boston, MA26 studi
- Philadelphia, PA23 studi
- San Francisco, CA22 studi
- Atlanta, GA21 studi
- St. Louis, MO21 studi
- Columbus, OH21 studi
- Salt Lake City, UT21 studi
Altri studi a Durham
- Cancro al seno63 studi
- Cancro (tutti i tipi)58 studi
- Cancro del polmone non a piccole cellule39 studi
- Mieloma multiplo37 studi
- Cancro metastatico33 studi
- Leucemia mieloide acuta33 studi
- Cancro ai polmoni32 studi
- Cancro alla prostata32 studi
- Cancro colorettale28 studi
- Leucemia linfatica cronica27 studi
- Cancro ovarico27 studi
- Insufficienza cardiaca26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.